{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:52:11Z","timestamp":1791748331177,"version":"4.3.4"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:p>Strongyloides stercoralis can cause life-threatening infections. Subcutaneous veterinary formulations of ivermectin (IVM) may be the only option for severe treatment, but the dosage and duration are empirical. This article, based on a clinical case, discusses ivermectin concentrations and proposes clinical and parasitological follow-up to guide parenteral therapy in severe strongyloidiasis.<\/jats:p>","DOI":"10.1093\/jtm\/taaf122","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:09:55Z","timestamp":1764335395000},"source":"Crossref","is-referenced-by-count":1,"title":["Subcutaneous ivermectin treatment in severe strongyloidiasis: is it time to recommend drug concentration measurements and parasitological stool monitoring follow-up?"],"prefix":"10.1093","volume":"33","author":[{"given":"Andrea","family":"Allg\u00f6wer","sequence":"first","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lespine","sequence":"additional","affiliation":[{"name":"INTHERES, Universit\u00e9 de Toulouse, INRAE, ENVT , 31076 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bastid","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigiriya","family":"Aebischer Perone","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Alcoba","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Sutra","sequence":"additional","affiliation":[{"name":"INTHERES, Universit\u00e9 de Toulouse, INRAE, ENVT , 31076 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Mauris","sequence":"additional","affiliation":[{"name":"Parasitology Laboratory, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"G\u00e9taz","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Geneva , 1206 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Geneva , 1206 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Eperon","sequence":"additional","affiliation":[{"name":"Division of Tropical and Humanitarian Medicine, Department of Community and Primary Care Medicine, Geneva University Hospitals (HUG) , 1205 Geneva ,","place":["Switzerland"]},{"name":"Faculty of Medicine, University of Geneva , 1206 Geneva ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026030305363787700_ref1","first-page":"1","volume-title":"WHO Guideline on Preventive Chemotherapy for Public Health Control of Strongyloidiasis","author":"World Health Organization","year":"2024"},{"key":"2026030305363787700_ref2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/jac\/dkv315","article-title":"Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature: table 1","volume":"71","author":"Barrett","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2026030305363787700_ref3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijantimicag.2013.07.015","article-title":"Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature","volume":"42","author":"Donadello","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2026030305363787700_ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2026030305363787700_ref5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.4269\/ajtmh.18-0387","article-title":"Case report: subcutaneous ivermectin pharmacokinetics in disseminated Strongyloides infection: plasma and Postmortem analysis","volume":"99","author":"Konecny","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2026030305363787700_ref6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2885.2005.00655.x","article-title":"Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein","volume":"28","author":"Griffin","year":"2005","journal-title":"J Vet Pharmacol Ther"},{"key":"2026030305363787700_ref7","volume-title":"Tablets Stromectol\u00ae (ivermectin)","author":"","year":"2022"},{"key":"2026030305363787700_ref8","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00204-021-03025-z","article-title":"Metabolism and interactions of ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects","volume":"95","author":"Rendic","year":"2021","journal-title":"Arch Toxicol"},{"key":"2026030305363787700_ref9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/cid\/cit656","article-title":"Persistent coma in Strongyloides hyperinfection syndrome associated with persistently increased ivermectin levels","volume":"58","author":"Van Westerloo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026030305363787700_ref10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMc1917344","article-title":"Serious ivermectin toxicity and human ABCB1 nonsense mutations","volume":"383","author":"Baudou","year":"2020","journal-title":"N Engl J Med"},{"key":"2026030305363787700_ref11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.4269\/ajtmh.2005.73.911","article-title":"Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis","volume":"73","author":"Turner","year":"2005","journal-title":"Am J Trop Med Hyg"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taaf122\/65665871\/taaf122.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/33\/2\/taaf122\/65665871\/taaf122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/33\/2\/taaf122\/65665871\/taaf122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:36:41Z","timestamp":1772534201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taaf122\/8362126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taaf122","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,1]]},"article-number":"taaf122"}}